| Trial ID: | L6834 |
| Source ID: | NCT00980187
|
| Associated Drug: |
Hydrochlorothiazide
|
| Title: |
A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM
|
| Acronym: |
AISHA
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Hydrochlorothiazide|DRUG: Indapamide
|
| Outcome Measures: |
Primary: Better metabolic effects of indapamide SR 1.5 mg+quinapril by comparison with hydrochlorothiazide 25 mg+quinapril, in patients with hypertension and type 2 diabetes mellitus., 6 months | Secondary: Better antihypertensive effects of indapamide SR 1.5 mg+quinapril by comparison with hydrochlorothiazide 25 mg+quinapril, in patients with hypertension and type 2 diabetes mellitus., 6 months|Better effects on cardiac and arterial function of indapamide SR 1.5 mg+quinapril by comparison with hydrochlorothiazide 25 mg+quinapril, in patients with hypertension and type 2 diabetes mellitus, 6 months|Better safety of indapamide SR 1.5 mg+quinapril by comparison with hydrochlorothiazide 25 mg+quinapril, in patients with hypertension and type 2 diabetes mellitus, 6 months
|
| Sponsor/Collaborators: |
Sponsor: LaborMed Pharma S.A.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-03
|
| Completion Date: |
2010-08
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-15
|
| Locations: |
Cardiology, University and Emergency Hospital, Bucharest, 050098, Romania
|
| URL: |
https://clinicaltrials.gov/show/NCT00980187
|
